<DOC>
	<DOCNO>NCT02327741</DOCNO>
	<brief_summary>1010 patient post stenting enrol receive Plavix 12 month less rate bleeding , complication major cardiovascular adverse event ( MACE ) compare evaluate safety feasibility long term Plavix therapy post stenting .</brief_summary>
	<brief_title>Efficacy Long Term Plavix Therapy Post Angioplasty</brief_title>
	<detailed_description>1010 patient registry angioplasty stenting Shiraz Baghiatolah hospital enrol long term Plavix therapy le 12 month compare two group patient prospectively rate major adverse cardiovascular event ( MACE ) ( death , myocardial infarction , cerebrovascular accident revascularization ) rate bleeding compare 2 groups.Syntax score American heart association ( AHA ) score coronary involvement measure MACE compare score .</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>post stent ( lesion 70 % vessel 2.25 mm ) allergy acetylsalicylic acid clopidogrel , plan surgery within 24 month percutaneous coronary intervention unless dual antiplatelet therapy could maintain throughout perisurgical period history bleed diathesis major surgery within 15 day active bleed previous stroke past 6 month concomitant foreseeable need oral anticoagulation therapy pregnancy , life expectancy &lt; 24 month , participation another trial inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Dual antiplatelet therapy</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>percutaneous coronary intervention</keyword>
</DOC>